Research shows new treatment could delay cancer progression in patients with high-risk smoldering multiple myeloma – Mayo Clinic News Network

ROCHESTER, Minn. — A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk SMM carries a higher likelihood of progression. Results from a phase 3 clinical trial, published in the New England Journal of Medicine and […]

Read the full article here

Source: newsnetwork.mayoclinic.org

Categories: General HCPs, General Medicine News

Tweets with this article

Mayo Clinic

A new treatment is changing the outlook for high-risk smoldering multiple myeloma (SMM). Results from a phase 3 clinical trial show that daratumumab reduces the risk of progression to active multiple myeloma and improves overall survival. Learn more: https://t.co/mEKvkwGxP0 https://t.co/kZLXNtvqW4

Related Articles

Massive study uncovers how much exercise is needed to live longer

What is the ideal amount of physical activity that can help individuals live longer? Learn more about what the ideal exercise volume per week is.

AMA December 26, 2024

Peter’s Story | Foot and Ankle Patient Stories

After a successful ankle surgery, Rochester Hills resident, Peter Hotaling, scored a comeback to hockey.

Henry Ford Health System December 26, 2024

Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study

Among influenza patients hospitalized during 2022–2023 influenza season, initiating treatment with oseltamivir on the day of admission (compared with later

Adam Cifu December 26, 2024

Landmark photosynthesis gene discovery boosts plant height, advances crop science

A team of scientists with two Department of Energy Bioenergy Research Centers — the Center for Bioenergy Innovation, or CBI, at Oak Ridge National Laboratory…

EurekAlert! December 26, 2024

If TikTok Goes, So Do These People’s Livelihoods

As the threat of a TikTok shutdown looms in the new year, small business owners say a ban would cut into their bottom line

Evan Kirstel the $B2B Techfluencer December 26, 2024

Ischemic Monomelic Neuropathy After Dialysis Access Creation Requiring Emergent Fistula Ligation

Ischemic monomelic neuropathy (IMN) is a rare but potentially devastating complication of arteriovenous fistula (AVF) creation.1 The exact pathophysiologic mechanism and incidence of IMN are…

MayoProceedings December 26, 2024

Does Magnesium Help You Sleep Better?

The internet is full of sleep remedies. So, what about taking magnesium supplements? An integrative medicine specialist shares what research shows.

Cleveland Clinic December 26, 2024

Governing global health with a planetary mindset

In 2023, a disturbing milestone was reached: six out of nine planetary boundaries were crossed, signalling an unprecedented threat to Earth’s stability.1 Simultaneously, the world…

The BMJ December 26, 2024

Young Gay Latinos See Rising Share of New HIV Cases, Leading to Call for Targeted Funding – KFF Health News

Since being diagnosed with HIV in 2022, Fernando Hermida has had to move three times to access treatment. A KFF Health News-Associated Press analysis found…

Kaiser Health News December 26, 2024

Germany’s biggest car maker is on the ropes… and the truth is shocking

The good life is over at Volkswagen. With group profits down 64 per cent in the third quarter of 2024 and the core VW brand…

Evan Kirstel the $B2B Techfluencer December 26, 2024